Wedbush Forecasts Stronger Earnings for Apogee Therapeutics
Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Research analysts at Wedbush upped their Q2 2025 EPS estimates for shares of Apogee Therapeutics in a note issued to investors on Monday, May 12th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($1.03) per share for the quarter, up from their […]
Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Research analysts at Wedbush upped their Q2 2025 EPS estimates for shares of Apogee Therapeutics in a note issued to investors on Monday, May 12th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($1.03) per share for the quarter, up from their […]
